Skyhawk Therapeutics

Skyhawk Therapeutics

Skyhawk Therapeutics

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.
Raised
$48M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$8,000,000
Seed fund - 2018
Tim Disney Alexandria Venture Investments The Duke of Bedford
Team Size
1–10
Employees
$40,000,000 Venture capital
PE HUB

Skyhawk Therapeutics lands $40 mln

Messaging Data leaks
FinSMEs

Skyhawk Therapeutics Raises $8M in Seed Financing

Science Funding